TY - JOUR AU - Horoszewicz, J. S. AU - Kawinsky, E. M. G. PY - 1987 DA - 1987// TI - Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients JO - Anticancer Res VL - 7 ID - Horoszewicz1987 ER - TY - JOUR AU - Israeli, R. S. AU - Powell, C. T. AU - Corr, J. G. AU - Fair, W. R. AU - Heston, W. D. PY - 1994 DA - 1994// TI - Expression of the prostate-specific membrane antigen JO - Cancer Res VL - 54 ID - Israeli1994 ER - TY - JOUR AU - Wright, G. L. AU - Haley, C. AU - Lou, B. M. AU - Schellhammer, P. F. PY - 1995 DA - 1995// TI - Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues JO - Urol Oncol Semin Orig Investig VL - 1 UR - https://doi.org/10.1016/1078-1439(95)00002-Y DO - 10.1016/1078-1439(95)00002-Y ID - Wright1995 ER - TY - JOUR AU - Ross, J. S. AU - Sheehan, C. E. AU - Fisher, H. A. G. PY - 2003 DA - 2003// TI - Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer JO - Clin Cancer Res VL - 9 ID - Ross2003 ER - TY - JOUR AU - Afshar-Oromieh, A. AU - Hetzheim, H. AU - Kratochwil, C. PY - 2015 DA - 2015// TI - The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.161299 DO - 10.2967/jnumed.115.161299 ID - Afshar-Oromieh2015 ER - TY - STD TI - Backhaus P, Noto B, Avramovic N, et al. Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives. Eur J Nucl Med Mol Imaging. 2018;45(5):860–77. https://doi.org/10.1007/s00259-017-3922-y. Epub 2018 Jan 15. ID - ref6 ER - TY - JOUR AU - Wolf, P. AU - Freudenberg, N. AU - Bühler, P. PY - 2010 DA - 2010// TI - Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer JO - Prostate VL - 70 ID - Wolf2010 ER - TY - JOUR AU - Chang, S. S. AU - Reuter, V. E. AU - Heston, W. D. W. AU - Bander, N. H. AU - Grauer, L. S. AU - Gaudin, P. B. PY - 1999 DA - 1999// TI - Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated Neovasculature JO - Cancer Res VL - 59 ID - Chang1999 ER - TY - JOUR AU - Silver, D. A. AU - Pellicer, I. AU - Fair, W. R. AU - Heston, W. D. AU - Cordon-Cardo, C. PY - 1997 DA - 1997// TI - Prostate-specific membrane antigen expression in normal and malignant human tissues JO - Am Assoc Cancer Res VL - 3 ID - Silver1997 ER - TY - STD TI - Klein Nulent TJW, van Es RJJ, Krijger GC, de Bree R, Willems SM, de Keizer B. Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis. Eur J Nucl Med Mol Imaging. 2017;44(10):1614–21. https://doi.org/10.1007/s00259-017-3737-x. Epub 2017 Jun 7. ID - ref10 ER - TY - JOUR AU - Spiro, R. H. AU - Huvos, A. G. AU - Strong, E. W. PY - 1974 DA - 1974// TI - Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases JO - Am J Surg VL - 128 UR - https://doi.org/10.1016/0002-9610(74)90265-7 DO - 10.1016/0002-9610(74)90265-7 ID - Spiro1974 ER - TY - BOOK PY - 2015 DA - 2015// TI - Incidence of invasive salivary gland cancer per year ID - ref12 ER - TY - STD TI - de Ridder M, Balm AJM, Smeele LE, Wouters MWJM, van BAC D. An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010). Cancer Epidemiol. 2015;39(1):14–20. https://doi.org/10.1016/j.canep.2014.10.007. Epub 2014 Nov 15. ID - ref13 ER - TY - JOUR AU - Bjørndal, K. AU - Krogdahl, A. AU - Therkildsen, M. H. PY - 2011 DA - 2011// TI - Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish head and neck Cancer group (DAHANCA) JO - Oral Oncol VL - 47 UR - https://doi.org/10.1016/j.oraloncology.2011.04.020 DO - 10.1016/j.oraloncology.2011.04.020 ID - Bjørndal2011 ER - TY - JOUR AU - Jang, S. AU - Patel, P. N. AU - Kimple, R. J. AU - McCulloch, T. M. PY - 2017 DA - 2017// TI - Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the head and neck JO - Anticancer Res VL - 37 ID - Jang2017 ER - TY - JOUR AU - Coca-Pelaz, A. AU - Rodrigo, J. P. AU - Bradley, P. J. PY - 2015 DA - 2015// TI - Adenoid cystic carcinoma of the head and neck - an update JO - Oral Oncol VL - 51 UR - https://doi.org/10.1016/j.oraloncology.2015.04.005 DO - 10.1016/j.oraloncology.2015.04.005 ID - Coca-Pelaz2015 ER - TY - BOOK AU - Hellquist, H. AU - Skalova, A. PY - 2014 DA - 2014// TI - Adenoid Cystic Carcinoma. Histopathol PB - Salivary Gland., Springer CY - Berlin Heidelberg ID - Hellquist2014 ER - TY - JOUR AU - Weert, S. AU - Reinhard, R. AU - Bloemena, E. PY - 2017 DA - 2017// TI - Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck JO - Head Neck VL - 39 UR - https://doi.org/10.1002/hed.24613 DO - 10.1002/hed.24613 ID - Weert2017 ER - TY - JOUR AU - Ciccolallo, L. AU - Licitra, L. AU - Cantú, G. AU - Gatta, G. PY - 2009 DA - 2009// TI - Survival from salivary glands adenoid cystic carcinoma in European populations JO - Oral Oncol VL - 45 UR - https://doi.org/10.1016/j.oraloncology.2008.10.010 DO - 10.1016/j.oraloncology.2008.10.010 ID - Ciccolallo2009 ER - TY - STD TI - Hofman MS, Violet J, Hicks RJ, et al. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Lancet Oncol. 2018;19(6):825–33. https://doi.org/10.1016/S1470-2045(18)30198-0. Epub 2018 May 8. ID - ref20 ER - TY - JOUR AU - Perzin, K. H. AU - Gullane, P. AU - Clairmont, A. C. PY - 1978 DA - 1978// TI - Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course JO - Cancer VL - 42 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Perzin1978 ER - TY - JOUR AU - Heinze, G. AU - Dunkler, D. PY - 2008 DA - 2008// TI - Avoiding infinite estimates of time-dependent effects in small-sample survival studies JO - Stat Med VL - 27 UR - https://doi.org/10.1002/sim.3418 DO - 10.1002/sim.3418 ID - Heinze2008 ER - TY - JOUR AU - Harrell, F. E. H. AU - Lee, K. L. AU - Mark, D. B. PY - 1996 DA - 1996// TI - Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measurin and reducing errors JO - Stat Med VL - 15 UR - https://doi.org/3.0.CO;2-4 DO - 3.0.CO;2-4 ID - Harrell1996 ER - TY - JOUR AU - Wright, G. L. AU - Mayer Grob, B. AU - Haley, C. PY - 1996 DA - 1996// TI - Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy JO - Urology VL - 48 UR - https://doi.org/10.1016/S0090-4295(96)00184-7 DO - 10.1016/S0090-4295(96)00184-7 ID - Wright1996 ER - TY - JOUR AU - Perico, M. E. AU - Grasso, S. AU - Brunelli, M. PY - 2016 DA - 2016// TI - Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells “in vitro” and correlating with progression “in vivo.” JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.12404 DO - 10.18632/oncotarget.12404 ID - Perico2016 ER - TY - JOUR AU - Kaittanis, C. AU - Andreou, C. AU - Hieronymus, H. PY - 2018 DA - 2018// TI - Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors JO - J Exp Med VL - 215 UR - https://doi.org/10.1084/jem.20171052 DO - 10.1084/jem.20171052 ID - Kaittanis2018 ER - TY - JOUR AU - Mhawech-Fauceglia, P. AU - Smiraglia, D. J. AU - Bshara, W. PY - 2008 DA - 2008// TI - Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma JO - Cancer Epidemiol Biomark Prev VL - 17 UR - https://doi.org/10.1158/1055-9965.EPI-07-0511 DO - 10.1158/1055-9965.EPI-07-0511 ID - Mhawech-Fauceglia2008 ER - TY - STD TI - Salas Fragomeni RA, Amir T, Sheikhbahaei S, et al. Imaging of Non-Prostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms. J Nucl Med. 2018. https://doi.org/10.2967/jnumed.117.203570. ID - ref28 ER - TY - STD TI - Klein Nulent TJW, Valstar MH, de Keizer B, et al. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018. ID - ref29 ER - TY - JOUR AU - Rothman, K. J. PY - 1990 DA - 1990// TI - No adjustments are needed for multiple comparisons JO - Epidemiology VL - 1 UR - https://doi.org/10.1097/00001648-199001000-00010 DO - 10.1097/00001648-199001000-00010 ID - Rothman1990 ER - TY - JOUR AU - Alfieri, S. AU - Granata, R. AU - Bergamini, C. PY - 2017 DA - 2017// TI - Systemic therapy in metastatic salivary gland carcinomas: a pathology-driven paradigm? JO - Oral Oncol VL - 66 UR - https://doi.org/10.1016/j.oraloncology.2016.12.016 DO - 10.1016/j.oraloncology.2016.12.016 ID - Alfieri2017 ER - TY - JOUR AU - Has Simsek, D. AU - Kuyumcu, S. AU - Agaoglu, F. Y. AU - Unal, S. N. PY - 2019 DA - 2019// TI - Radionuclide therapy with 177Lu-PSMA in a case of metastatic adenoid cystic carcinoma of the parotid JO - Clin Nucl Med VL - 44 UR - https://doi.org/10.1097/RLU.0000000000002645 DO - 10.1097/RLU.0000000000002645 ID - Has Simsek2019 ER - TY - JOUR AU - Rahbar, K. AU - Boegemann, M. AU - Yordanova, A. PY - 2018 DA - 2018// TI - PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival JO - Eur J Nucl Med Mol Imaging VL - 45 UR - https://doi.org/10.1007/s00259-017-3848-4 DO - 10.1007/s00259-017-3848-4 ID - Rahbar2018 ER -